Literature DB >> 17962094

The COMT val158met polymorphism is associated with prevalent fractures in Swedish men.

Anna L Eriksson1, Dan Mellström, Mattias Lorentzon, Eric S Orwoll, Inga Redlund-Johnell, Elin Grundberg, Anna Holmberg, Osten Ljunggren, Magnus K Karlsson, Claes Ohlsson.   

Abstract

INTRODUCTION: Sex steroids are important for growth and maintenance of the skeleton. Catechol-O-methyltransferase (COMT) is an estrogen degrading enzyme. The COMT val158met polymorphism results in a 60-75% difference in enzyme activity between the val (high activity=H) and met (low activity=L) variants. We have previously reported that this polymorphism is associated with bone mineral density (BMD) in young men. The aim of this study was to investigate associations between COMT val158met, BMD and fractures in elderly men.
METHODS: Population-based study of Swedish men 75.4, SD 3.2, years of age. Fractures were reported using standardized questionnaires. Fracture and genotype data were available from 2,822 individuals.
RESULTS: Total number of individuals with self-reported fracture was 989 (35.0%). Prevalence of >or=1 fracture was 37.2% in COMT(LL), 35.7% in COMT(HL) and 30.4% in COMT(HH) (p<0.05). Early fractures (<or=50 years of age) were less common in COMT(HH) than in the combined COMT(LL+HL) genotype, OR 0.78 (95% CI 0.63-0.97). No associations were found for late fractures (>50 years of age). The OR for fracture of the non-weight bearing skeleton in COMT(HH) compared with COMT(LL+HL) was 0.74 (95% CI 0.59-0.92). No associations between COMT val158met and BMD were found in this cohort of elderly men.
CONCLUSIONS: The COMT val158met polymorphism is associated with life time fracture prevalence in elderly Swedish men. This association is mainly driven by early fractures (<or=50 years of age).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962094     DOI: 10.1016/j.bone.2007.08.045

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

Review 2.  Bone health in ageing men.

Authors:  Karel David; Nick Narinx; Leen Antonio; Pieter Evenepoel; Frank Claessens; Brigitte Decallonne; Dirk Vanderschueren
Journal:  Rev Endocr Metab Disord       Date:  2022-07-16       Impact factor: 9.306

Review 3.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

Review 4.  Androgens and estrogens in skeletal sexual dimorphism.

Authors:  Michaël Laurent; Leen Antonio; Mieke Sinnesael; Vanessa Dubois; Evelien Gielen; Frank Classens; Dirk Vanderschueren
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

5.  Bone mineral density in high-level endurance runners: Part B-genotype-dependent characteristics.

Authors:  A J Herbert; A G Williams; S J Lockey; R M Erskine; C Sale; P J Hennis; S H Day; G K Stebbings
Journal:  Eur J Appl Physiol       Date:  2021-09-22       Impact factor: 3.078

6.  Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans.

Authors:  Mandana Ghisari; Manhai Long; Eva C Bonefeld-Jørgensen
Journal:  Int J Circumpolar Health       Date:  2013-06-17       Impact factor: 1.228

7.  A genome-wide association study demonstrates significant genetic variation for fracture risk in Thoroughbred racehorses.

Authors:  Sarah C Blott; June E Swinburne; Charlene Sibbons; Laura Y Fox-Clipsham; Maud Helwegen; Lynn Hillyer; Tim D H Parkin; J Richard Newton; Mark Vaudin
Journal:  BMC Genomics       Date:  2014-02-21       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.